Akeso has been growing earnings at an average annual rate of 11.7%, while the Biotechs industry saw earnings growing at 17.4% annually. Revenues have been growing at an average rate of 37.9% per year.
Key information
11.69%
Earnings growth rate
15.20%
EPS growth rate
Biotechs Industry Growth
-14.59%
Revenue growth rate
37.87%
Return on equity
-12.75%
Net Margin
-36.42%
Last Earnings Update
31 Dec 2025
Recent past performance updates
Recent updates
Revenue & Expenses Breakdown
How Akeso makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
DB:4RY Revenue, expenses and earnings (CNY Millions)
Date
Revenue
Earnings
G+A Expenses
R&D Expenses
31 Dec 25
3,056
-1,113
1,733
1,575
30 Sep 25
2,784
-980
1,563
1,450
30 Jun 25
2,511
-846
1,394
1,325
31 Mar 25
2,317
-680
1,300
1,256
31 Dec 24
2,124
-515
1,205
1,188
30 Sep 24
1,999
-625
1,184
1,231
30 Jun 24
1,874
-735
1,164
1,274
31 Mar 24
3,200
646
1,127
1,264
31 Dec 23
4,526
2,028
1,090
1,254
30 Sep 23
4,439
2,008
1,071
1,278
30 Jun 23
4,351
1,987
1,052
1,302
31 Mar 23
2,595
409
902
1,313
31 Dec 22
838
-1,168
752
1,323
30 Sep 22
549
-1,224
672
1,239
30 Jun 22
260
-1,280
592
1,155
31 Mar 22
243
-1,178
508
1,139
31 Dec 21
226
-1,075
423
1,123
30 Sep 21
177
-1,002
324
1,107
30 Jun 21
129
-929
226
1,091
31 Mar 21
64
-983
240
930
31 Dec 20
0
-1,036
253
769
30 Sep 20
35
-870
197
597
30 Jun 20
71
-703
141
426
31 Mar 20
71
-492
98
367
31 Dec 19
71
-282
55
308
31 Dec 18
3
-142
20
161
Quality Earnings: 4RY is currently unprofitable.
Growing Profit Margin: 4RY is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 4RY is unprofitable, but has reduced losses over the past 5 years at a rate of 11.7% per year.
Accelerating Growth: Unable to compare 4RY's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: 4RY is unprofitable, making it difficult to compare its past year earnings growth to the Biotechs industry (45%).
Return on Equity
High ROE: 4RY has a negative Return on Equity (-12.75%), as it is currently unprofitable.
Return on Assets
Return on Capital Employed
Discover strong past performing companies
7D
1Y
7D
1Y
7D
1Y
Company Analysis and Financial Data Status
Data
Last Updated (UTC time)
Company Analysis
2026/05/02 03:27
End of Day Share Price
2026/04/30 00:00
Earnings
2025/12/31
Annual Earnings
2025/12/31
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Akeso, Inc. is covered by 34 analysts. 19 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.